Breast cancer overview.
The words, "you have breast cancer," is possibly one of the most devastating statements an individual could image hearing from his or her physician even though breast cancer is the most common cancer among women. The diagnosis bears a significant amount of anxiety and fear in regards to treatment and overall survival. However, research has increased healthcare professionals' knowledge on the benefits of early screening, diagnosis, and treatments, which has steadily reduced the death rate from breast cancer over the past 20 years. Physicians are better able to predict how particular breast cancers will react to treatment; therefore, they are able to choose more effective treatment options based on these findings. The goal of this article is to highlight the incidence, staging and diagnostic studies, types, treatments, and follow-up of breast cancer dispelling some of the common societal stigmas and unfounded fears surrounding this diagnosis.
Ely
Susan
S
West Penn Allegheny Health System, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA. AVIORAL@wpahs.org
Vioral
Anna N
AN
D000359:Aftercare; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001294:Attitude to Health; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D016504:Breast Self-Examination; D017024:Chemotherapy, Adjuvant; D016503:Drug Delivery Systems; D005239:Fear; D005260:Female; D006801:Humans; D015994:Incidence; D008279:Magnetic Resonance Imaging; D008327:Mammography; D008403:Mass Screening; D008408:Mastectomy; D009367:Neoplasm Staging; D024802:Nurse's Role; D009859:Oncology Nursing; D010166:Palliative Care; D018714:Radiotherapy, Adjuvant; D013240:Stereotyping; D014481:United States / Q000453:epidemiology
D000970:Antineoplastic Agents